Skip to content

    Centum Electron

    CENTUMGood
    Capital Goods·6 Aug 2025
    Management Summary

    Centum Electronics delivered a strong Q1 FY26, driven by robust standalone performance in the high-margin build-to-spec business for domestic defense and space customers. While international subsidiaries faced degrowth and continued losses, management is actively pursuing strategic actions to address these. The company's order book remains healthy, supported by new EMS customers and development orders, with a positive outlook for the second half of the financial year.

    Highlights

    8
    • Consolidated revenue from operations grew by 11.4% year-on-year to Rs. 273 crores.

    • Standalone revenue from operations increased by 35% year-on-year to Rs. 180 crores.

    • Consolidated EBITDA grew by 47% year-on-year to Rs. 23 crores, with an EBITDA margin of 8.38%.

    • Standalone EBITDA grew by over 100% year-on-year to Rs. 27 crores, with an EBITDA margin of 14.92%.

    • Consolidated net profit was Rs. 4.5 crores (PAT margin 1.65%), while standalone net profit surged by over 250% to Rs. 16.5 crores.

    • Order book position grew to Rs. 1,769 crores as of June 30, 2025.

    • New development orders received from DRDO for critical programs like the Virupaksha Radar.

    • Canadian subsidiary incurred an EBT loss of €600,000 - €700,000 in Q1 FY26, with strategic actions underway to stop losses.

    Concerns

    1
    • Continued losses from Canadian subsidiary

    What Changed1

    vs Q2 FY26

    Risks discussed3 → 4 (+1)

    Key financials

    Single quarter

    10 metrics
    1. 01Consolidated Revenue₹273 Cr+11.4%YoY
    2. 02Standalone Revenue₹180 Cr+35%YoY
    3. 03Consolidated EBITDA₹23 Cr+47%YoY
    4. 04Standalone EBITDA₹27 Cr+100%YoY
    5. 05Consolidated EBITDA Margin8.4%

    Segment breakdown

    Order Book Split
    ₹710 Cr EMS Order Book₹886 Cr BTS Order Book₹171 Cr ER&D Service Order Book
    List

    Guidance & targets

    8
    CategoryTargetPriority
    Performance
    International Subsidiaries Performance
    better performance
    Medium
    Growth
    Consolidated Revenue Growth Rate
    18% to 20%
    Medium
    Growth
    Standalone Business Growth Rate (Build-to-spec & EMS)
    25% plus
    Medium
    Profitability
    Consolidated EBITDA Margin
    13% to 15%
    Medium
    Profitability
    Subsidiary EBITDA Margin
    10% - 11%
    Medium
    Capex
    Standalone Capex
    Rs. 40 crores
    High
    Revenue
    Revenue from NPI qualifications
    USD 15 million
    High
    Capacity
    Standalone Utilization (Gross Block)
    8x to 9x
    Medium

    Risks & concerns

    6
    RiskSeverity

    Continued losses from Canadian subsidiary

    The Canadian subsidiary lost ~€2.4 million in FY25 and ~€600,000-€700,000 in Q1 FY26 (EBT level), with management actively exploring options to stop the bleeding.Management acknowledged

    high

    Degrowth in international subsidiaries

    Demand in ER&D business is yet to pick up due to delays in customer decisions in Europe, impacting international subsidiary performance.Management acknowledged

    medium

    Dependence on government processes for large orders

    While a healthy pipeline exists for large tri-services orders, actual booking depends on government approval processes, which can cause delays.Management acknowledged

    medium

    Stalled Indra Sistemas program

    The Indra Sistemas program remains stalled with no further updates from the government.Management acknowledged

    low

    Areas of Evasion(2)

    • Specific cash inflow from Canadian subsidiary sale
    • Exact pie size of SBS-3 project

    Q&A highlights

    3

    “Yes, I am not able to disclose anything of that sort at the moment. And also, you should remember this is a loss making business, so the expectation of any significant cash in is not high.”

    Reveals the financial distress of the Canadian subsidiary and the limited cash inflow expected from its divestment, indicating a focus on stopping losses rather than generating significant capital.

    asked by Raman KV

    3 min read7 chapters

    Detailed Narrative

    01

    Strong Q1 FY26 Performance Driven by Standalone Business

    Centum Electronics reported a robust Q1 FY26, with consolidated revenue growing 11.4% year-on-year to Rs. 273 crores. This was primarily fueled by a 35% year-on-year growth in standalone revenue, reaching Rs. 180 crores, largely attributed to the high-margin build-to-spec business for domestic defense and space customers. Standalone EBITDA surged over 100% to Rs. 27 crores, achieving a margin of 14.92%, while consolidated EBITDA grew 47% to Rs. 23 crores with an 8.38% margin.

    02

    Healthy Order Book and Strategic Development Orders

    The company's order book expanded to Rs. 1,769 crores as of June 30, 2025, indicating strong future revenue visibility. The order book is split with Rs. 710 crores for EMS, Rs. 886 crores for BTS, and Rs. 171 crores for ER&D services. Centum also secured new development orders from DRDO for critical programs like the Virupaksha Radar, a ~Rs. 10 crore order for the Sukhoi-30 platform, which is expected to unlock a significant long-term opportunity of around Rs. 1,000 crores.

    03

    Addressing International Subsidiary Losses

    International subsidiaries experienced degrowth, with the Canadian entity being a significant drag. In Q1 FY26, the Canadian subsidiary incurred an EBT loss of €600,000-€700,000, following losses of ~€2.4 million in FY25. Management is actively exploring strategic actions, including potential divestment or repositioning, aiming to finalize a decision by the end of the current quarter to stop the bleeding.

    04

    Margin Improvement Roadmap Focused on Subsidiaries

    While standalone EBITDA margins are healthy at 14.92%, consolidated margins are lower at 8.38% due to the underperformance of international subsidiaries. The company's objective is to achieve a consolidated EBITDA margin of 13-15%. The roadmap for improvement includes maintaining standalone margins and significantly improving subsidiary margins from ~1.5% to 10-11% over the next two years by focusing sales efforts on defense and aerospace customers in France and resolving the Canadian losses.

    05

    Capex for Indian Business and Capacity Expansion

    Centum plans a CAPEX of Rs. 40 crores in FY26, exclusively for its Indian business, to augment capabilities and capacities. This investment is expected to improve asset utilization from the current 6x-7x to 8x-9x in the next 1-2 years. Management anticipates that this CAPEX will support an additional leg of growth, with a revenue turn of around 5x on gross block or 6x-7x on net block.

    06

    Diversified EMS Business and New Product Introductions

    The EMS business is well-diversified across defense, aerospace, industrial, energy, medical, automotive, semiconductor, and biometric security sectors, with a high level of recurring revenue and geographical spread across Europe, the U.S., and Asia. The company expects new product introduction (NPI) qualifications in semiconductor, biometric security, and export defense/aerospace to contribute approximately USD 15 million in revenue in FY26.

    07

    Long-Term Growth Outlook and Strategic Partnerships

    Centum targets a medium-term consolidated revenue growth rate of 18-20%, with standalone growth expected to be higher at 25% plus, driven by both build-to-spec and EMS segments. In the space sector, with an estimated opportunity size of USD 3-4 billion, Centum is pursuing a multi-pronged strategy, partnering with start-ups, working with ISRO on key programs, and collaborating with global companies to capture opportunities.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.